S 1930 · 119th Congress
Small Biotech Innovation Act
This bill creates an exception to Medicare's drug price negotiation program for small biotech companies that focus heavily on research and development. Starting in 2029, certain drugs made by these smaller companies won't be subject to the government's ability to negotiate lower prices. Here's who qualifies: A comp…
- Sponsor
- Cassidy, Bill (R-Louisiana)
- Introduced
- 2025-06-03
- Policy area
- Health
- Latest action
- Read twice and referred to the Committee on Finance.
Digging through Congress... 🔍